Received Apr 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | DN273 | IM / RL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y014437 | SC / LL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y015101 | SC / RL |
Patient received Varivax, ProQuad, and Hep A on 3/14/2025. Mother was notified regarding extra Varicella dose via Proquad product approx. an hour after administration. A follow up call 3/17/2025 to patient was made and mother reported patient did well over the week. He was afebrile, and immunization sites with no changes.
No active problem lists. Right acute otitis media 3/13/2025, Bilateral acute otitis media 2/24/2025. Bilateral acute otitis media 2/13/2024.
None.
No medications
No Known Allergies
None